Nutriband (NTRB)
(Delayed Data from NSDQ)
$7.10 USD
-0.42 (-5.59%)
Updated Oct 17, 2024 04:00 PM ET
After-Market: $7.11 +0.01 (0.14%) 7:00 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Nutriband Inc falls in the month of January .
All items in Millions except EPS data.
1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 | |
---|---|---|---|---|---|
Sales | 2 | 2 | 1 | 1 | 0 |
Cost Of Goods | 1 | 1 | 1 | 1 | 1 |
Gross Profit | 1 | 1 | 1 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 6 | 5 | 7 | 3 | 2 |
Income After Depreciation & Amortization | -5 | -4 | -6 | -3 | -2 |
Non-Operating Income | -1 | 0 | 0 | 0 | -1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -5 | -4 | -6 | -3 | -3 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -5 | -4 | -6 | -3 | -3 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -5 | -4 | -6 | -3 | -3 |
Depreciation Footnote | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -5 | -4 | -4 | -2 | -2 |
Depreciation & Amortization (Cash Flow) | 0 | 1 | 3 | 0 | 0 |
Income After Depreciation & Amortization | -5 | -4 | -6 | -3 | -2 |
Earnings Per Share Data | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Average Shares | 7.95 | 8.46 | 7.93 | 6.73 | 6.33 |
Diluted EPS Before Non-Recurring Items | -0.62 | -0.53 | -0.53 | -0.44 | -0.32 |
Diluted Net EPS (GAAP) | -0.69 | -0.53 | -0.81 | -0.44 | -0.43 |
Fiscal Year end for Nutriband Inc falls in the month of January .
All items in Millions except EPS data.
7/31/24 | 4/30/24 | 1/31/24 | 10/31/23 | 7/31/23 | |
---|---|---|---|---|---|
Sales | 0.44 | 0.41 | 0.52 | 0.43 | 0.66 |
Cost Of Goods | 0.34 | 0.24 | 0.34 | 0.27 | 0.36 |
Gross Profit | 0.10 | 0.16 | 0.18 | 0.16 | 0.30 |
SG&A, R&D, and Dept/Amort Expenses | 1.51 | 2.05 | 1.48 | 1.88 | 1.13 |
Income After SG&A, R&D, and Dept/Amort Expenses | -1.41 | -1.89 | -1.30 | -1.72 | -0.83 |
Non-Operating Income | -0.29 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.01 | 0.01 | 0.02 | 0.04 | 0.01 |
Pretax Income | -1.71 | -1.90 | -1.88 | -1.76 | -0.83 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -1.71 | -1.90 | -1.88 | -1.76 | -0.83 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -1.71 | -1.90 | -1.88 | -1.76 | -0.83 |
Earnings Per Share Data | 7/31/24 | 4/30/24 | 1/31/24 | 10/31/23 | 7/31/23 |
---|---|---|---|---|---|
Average Shares | 11.06 | 9.16 | 8.18 | 7.83 | 7.83 |
Diluted EPS Before Non-Recurring Items | -0.12 | -0.21 | -0.16 | -0.22 | -0.11 |
Diluted Net EPS (GAAP) | -0.15 | -0.21 | -0.23 | -0.22 | -0.11 |